Fate Therapeutics, Inc. (FATE)

1.485 -0.14 (-8.33%) USD  |  NASDAQ  |  Feb 25, 16:00
1.46 -0.02 (-1.68%) After-Hours: 20:00
More

Fate Therapeutics Financial Debt (Quarterly)

Financial Debt (Quarterly) Chart

View Financial Debt (Quarterly) for FATE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Financial Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Financial Debt Definition

View Financial Debt Definition
Start Trial

Amount of non-operational debt that a company has. This can be thought of as debt that is non-critical for a company's operations.

Read full definition.

Financial Debt (Quarterly) Range, Past 5 Years

View Financial Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Financial Debt (Quarterly) Benchmarks

View Financial Debt (Quarterly) Benchmarks
Start Trial
MannKind Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Ardelyx, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade